» Articles » PMID: 31934818

Longitudinal Assessment of the Platelet Transcriptome in Advanced Heart Failure Patients Following Mechanical Unloading

Overview
Journal Platelets
Publisher Informa Healthcare
Specialty Hematology
Date 2020 Jan 15
PMID 31934818
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with heart failure (HF) and left ventricular assist devices (LVAD) have dysregulated thrombo-inflammatory responses, mediated in part by platelets. While studies of platelet activation have been undertaken in HF, changes in the platelet transcriptome in HF patients following mechanical unloading with an LVAD have not been investigated. We prospectively enrolled and longitudinally followed advanced HF patients (n = 32) for a mean of 57 months post-LVAD implantation. For comparison, healthy donors were also enrolled (n = 20). Platelets were hyperactive in HF, as evidenced by significantly increased formation of circulating platelet-monocyte aggregate formation. Platelet transcriptome interrogation by next-generation RNA-sequencing identified that the expression of numerous genes (n = 588) was significantly (FDR < 0.05) altered in HF patients prior to LVAD implantation. Differentially expressed genes were predicted to have roles in angiogenesis, immune and inflammatory responses, apoptosis, and cardiac muscle contraction. 90 days following LVAD implantation, the majority (80%) of differentially expressed genes in HF patients normalized, as compared to the platelet transcriptomes of healthy donors. In conclusion, advanced HF is associated with marked alterations in the platelet transcriptome. While LVAD implantation to off load the failing heart results in resolution in the majority of differentially expressed genes, a subset of the platelet transcriptome remains persistently altered.

Citing Articles

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.

Cornwell M, El Bannoudi H, Luttrell-Williams E, Engel A, Barrett T, Myndzar K J Transl Med. 2023; 21(1):247.

PMID: 37029410 PMC: 10082503. DOI: 10.1186/s12967-023-04059-w.


A New Role of NAP1L1 in Megakaryocytes and Human Platelets.

Freitag M, Schwertz H Int J Mol Sci. 2022; 23(23).

PMID: 36499021 PMC: 9737020. DOI: 10.3390/ijms232314694.


Transcriptomic landscape of blood platelets in healthy donors.

Supernat A, Popeda M, Pastuszak K, Best M, Gresner P, In t Veld S Sci Rep. 2021; 11(1):15679.

PMID: 34344933 PMC: 8333095. DOI: 10.1038/s41598-021-94003-z.

References
1.
Shih L, Kaplan D, Kraiss L, Casper T, Pendleton R, Peters C . Platelet-Monocyte Aggregates and C-Reactive Protein are Associated with VTE in Older Surgical Patients. Sci Rep. 2016; 6:27478. PMC: 4895334. DOI: 10.1038/srep27478. View

2.
Rondina M, Carlisle M, Fraughton T, Brown S, Miller 3rd R, Harris E . Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci. 2014; 70(2):225-31. PMC: 4366600. DOI: 10.1093/gerona/glu082. View

3.
Koupenova M, Clancy L, Corkrey H, Freedman J . Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res. 2018; 122(2):337-351. PMC: 5777300. DOI: 10.1161/CIRCRESAHA.117.310795. View

4.
Mehra M, Goldstein D, Uriel N, Cleveland Jr J, Yuzefpolskaya M, Salerno C . Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018; 378(15):1386-1395. DOI: 10.1056/NEJMoa1800866. View

5.
Madden J, Drakos S, Stehlik J, McKellar S, Rondina M, Weyrich A . Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO J. 2014; 60(5):524-8. PMC: 4240532. DOI: 10.1097/MAT.0000000000000106. View